Home
GSC Biological and Pharmaceutical Sciences
Peer-reviewed Journal | Impact factor 8.1 | ISSN: 2581-3250 | CAS Source Indexed | Crossref DOI

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September 2026 - Vol. 36, Issue 3 

🌟 GSC Biological and Pharmaceutical Sciences (GSCBPS) 🌟

Low Publication Charges | Fast Editorial Processing | Crossref DOI Linking | Transparent Peer-Review Process

Publishing quality research in Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare and Allied Life Sciences.

e-ISSN: 2581-3250 | Impact Factor: 8.1 | Established: 2017 | Charges: USD 35 / INR 2100

📄 Submit Manuscript 👉 Author Guidelines 📚 Published Articles 

High faecal carriage of multi-drug resistant Enterobacteriaceae and other gram negative strains among food handlers in Cosmopolitan Cities of The Gambia

Breadcrumb

  • Home
  • High Faecal Carriage of Multi-drug Resistant Enterobacteriaceae and Other Gram Negative Strains Among Food Handlers In Cosmopolitan Cities of The Gambia
  • High faecal carriage of multi-drug resistant Enterobacteriaceae and other gram negative strains among food handlers in Cosmopolitan Cities of The Gambia

Bakary Sanneh 1, *, Ollie Diane Riley 1, Haruna S. Jallow 1, Abou Kebbeh 1, Yaya  Camara 2, Ebrima Barrow 3, Aida Fatou Ceesay 1, Modou Lamin  Jarju 1, Kalifa Sanneh 1, Sainey B.F. Ceesay 1, Amadou Woury Jallow 2, Alpha A  Jallow 4, Ignatius Baldeh 1, Sana M Sambou 2 and Antoine Andremont 5

1 National Public Health Laboratories, Bertil Herding High way, Kotu Lay out, Ministry of Health.
2 Epidemiology and Disease Control Unit, Bertil Herding High way, Kotu Lay out Ministry of Health, The Gambia.
3 Microbiology Laboratory department, Edward Francis Small Teaching Hospital ,Banjul, Ministry Of Health, The Gambia.
4 World Health Organization, Country Office, Kotu Lay out, The Gambia.
5 University Paris-Diderot Medical School, 5 Rue Thomas Mann, Paris, France.
Research Article
GSC Biological and Pharmaceutical Sciences, 2020, 13(02), 181-189.
Article DOI: 10.30574/gscbps.2020.13.2.0364
DOI url: https://doi.org/10.30574/gscbps.2020.13.2.0364
Received on 09 November 2020; revised on 15 November 2020; accepted on 16 November 2020
The introductions of advanced antibiotics have triggered complex versions of resistant genes in gram-negative bacteria. In a generation witness limited discovery of antibiotics makes this phenomenon a major public health threat. This study aims to establish the fecal carriage rate of multidrug-resistant Enterobacteriaceae strains among food handlers.
Data was extracted from a prospective cross-sectional study – ‘Prevalence and risk factors of fecal carriage of Extended Spectrum β-Lactamase producing Enterobacteriaceae amongst food handlers in Lower Basic Schools in West Coast region of The Gambia. The study enrolled 600 randomly selected food handlers (565 of which had complete data set) from 60 lower basic schools in 7 districts in the West Coast Region of The Gambia. Stool samples were collected from the participants and screened for resistance to cefotaxim. Isolated organisms were further tested for susceptibility to cephalosporins, carbapenems, fluoroquinolones and other families of antimicrobials as per Clinical Standard Laboratory Institute guidelines. The association of risk factors to fecal carriage of resistant Enterobacteriacea was performed using Pearson Chi squared and fishers exact (P<0.05).
Results confirmed that the prevalence of Enterobacteriaceae by resistance to cefotaxime was 15.8%. 23 genus and 89 species of resistant strains were isolated.  All isolates were 100% resistant to cephalosporins such as ceftriazone, cefotaxime and cefuroxime, except ceftazidime (92%). Resistance to ciprofloxacin (fluoroquinolone) was measured at 50%. Only 1.2% was resistant to imipenem (carbapenem). Most isolates were resistant to ampicillin, nitrofurantoine, erythromycin, tetracycline and cotrimaxole. Majority of the identified Enterobacteriaceae were Enterobacter aerogene (14%), Klebsiella pneumoniea (12%) and Escherichia coli (7%).
This study found a high prevalence of fecal carriage multi-drug resistant Enterobacteriaceae among food handlers, mostly women, in The Gambia. The irrational prescription and use of antibiotics is a major risk factor for the proliferation of antibiotic resistance. Well-conducted surveillance is essential to implement effective control measures for the spread of antibiotic resistance urgently receommended.
Fecal Carriage; Multi-Drug Resistant; Enterobacteriaceae; Food Handlers; The Gambia
 
https://gscbps.gsconlinepress.com/sites/default/files/fulltext_pdf/GSCBPS-2020-…

Preview Article PDF

Bakary Sanneh, Ollie Diane Riley, Haruna S. Jallow, Abou Kebbeh, Yaya Camara, Ebrima Barrow, Aida Fatou Ceesay, Modou Lamin Jarju, Kalifa Sanneh, Sainey B.F. Ceesay, Amadou Woury Jallow, Alpha A Jallow, Ignatius Baldeh, Sana M Sambou and Antoine Andremont. High faecal carriage of multi-drug resistant Enterobacteriaceae and other gram negative strains among food handlers in Cosmopolitan Cities of The Gambia. GSC Biological and Pharmaceutical Sciences, 2020, 13(2), 181-189. Article DOI: https://doi.org/10.30574/gscbps.2020.13.2.0364


📝 Copyright, Licensing and Permissions: © Copyright Author(s). This article is published under the 🌐 Creative Commons Attribution 4.0 International License (CC BY 4.0) , which permits unrestricted use, distribution, adaptation, and reproduction in any medium, provided the original author(s) and source are properly credited, a link to the license is provided, and any changes made are indicated.


⚠️ Disclaimer: The statements, opinions, interpretations, and data presented in this publication are solely those of the individual author(s). GSC Biological and Pharmaceutical Sciences (GSCBPS), the editors, reviewers, editorial board, and publisher disclaim responsibility for any errors, omissions, or consequences arising from the use of the information contained in this article.


🏆 Get Publication Certificate 📄 Download Letter of Acceptance 🔗 Verify Crossref DOI 📘 View Issue Cover Page 👨‍🔬 Editorial Board 📑 Table of Contents 

🚀 Publish Your Research in International Peer Reviewed Open Access Journal - GSC Biological and Pharmaceutical Sciences (GSCBPS)

Submit your manuscripts from Biological Sciences, Pharmaceutical Sciences, Medicine, Healthcare, Biotechnology and Allied Life Sciences etc.

🌍 International Journal   |   👨‍🔬 Transparent Peer Review Process   |   🌐 Open Access Publishing   |   🔗 Crossref DOI 
⚡ Fast Editorial Processing   |   💰 Low Publication Charges

📝 Submit Your Manuscript 📘 Author Guidelines 💰 Publication Charges 

✅ No Submission Fee •  📜 Free Publication Certificate • 🌍 Global Visibility

⭐ Popular Pages


  • 🌍 International Journal
  • 🌐 Open Access Journal
  • 👨‍⚖️ Peer-Reviewed Journal
  • 💰 Low APC Journal
  • 🚀 Fast Publication Journal
  • ⚡ Fast-Track Peer-Review
  • 🔗 Crossref DOI Journal
  • 📖 Refereed Journal
  • 📈 High Impact Journal
  • 🧬 International Biology Journal
  • 💊 International Pharmacy Journal
  • 📝 Publish Research Paper

✍️ Author Resources


  • 📝 Publish Research Paper
  • 📖 Author Guidelines
  • 🎯 Aims and Scope
  • 💳 Article Processing Charges
  • 📤 Submit Manuscript
  • 📄 Cover Letter
  • ✍️ Author Declaration Form
  • 📄Track Manuscript Status
  • 📜 Get Publication Certificate
  • 📚 Journal Past Issue Archive
  • 🔎 Journal Indexing

⚖️ Journal Policies


  • ⚖️ Publication Ethics
  • 🛡️ Plagiarism Policy
  • 👨‍🔬 Peer Review Policy
  • 👨‍⚖️ Peer Review Process
  • 📖 Open Access Publishing
  • 📜 Copyright & Licensing
  • 🔗Author Self-Archiving Policy
  • 👥 Authorship Policy
  • 📊 Data Sharing Policy
  • 🤖 AI Usage Policy

Copyright © 2026 GSC Biological and Pharmaceutical Sciences - All rights reserved

Developed & Designed by VS Infosolution